The relationship between potency of oxidative stress and severity of dilated cardiomyopathy

Canadian Journal of Cardiology

Volumn 21, Issue 10, 2005, Pages 851-855

  Demirbag, Recep ^a,c   Yilmaz, Remzi ^a   Erel, Ozcan ^a   Gultekin, Unal ^b   Asci, Dumus ^b   Elbasan, Zafer ^b  

^a HARRAN UNIVERSITY   (Turkey)

^b Sanliurfa State Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Dilated cardiomyopathy; Oxidants; Oxidative stress; Total antioxidants capacity

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; OXIDIZING AGENT; PEROXIDE; THIOL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION TEST; HUMAN; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; SUPPLEMENTATION; VITAMIN BLOOD LEVEL; VOLUNTEER;

AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HEART FUNCTION TESTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 25844478506     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. McMurray J, McLay J, Chopra M, Bridges A, Belch JJ. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;65:1261-2.
2. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176-86.
3. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods 1993;30:55-67.
4. Ball AM, Sole MJ. Oxidative stress and the pathogenesis of heart failure. Cardiol Clin 1998;16:665-75, viii-ix.
5. Singal PK, Khaper N, Palace V, Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998;40:426-32.
6. Schimke I, Muller J, Priem F, et al. Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol 2001;38:178-83.
7. Keith M, Geranmayegan A, Sole MJ, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol 1998;31:1352-6.
8. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991;65:245-8.
9. Prasad K, Kalra J, Bharadwaj L. Cardiac depressant effects of oxygen free radicals. Angiology 1993;44:257-70.
10. Sezgin N, Sezgin AT, Karabulut A, Topal E, Barutcu I, Gozukara EM. Comparison of the antioxidant enzyme levels with the degree of dysfunction in patients with myocardial dysfunction. Anadolu Kardiyol Derg 2004;4:130-4.
11. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-9.
12. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001;54:356-61.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
14. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
15. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 1999;299:15-27.
16. Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993;121:257-62.
17. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003;133:563-6.
18. Yucel D, Aydogdu S, Cehreli S, et al. Increased oxidative stress in dilated cardiomyopathic heart failure. Clin Chem 1998;44:148-54.
19. Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994;89:2829-35.
20. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996;148:291-300.
21. Kaul N, Siveski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 1995;11:551-4.
22. Balcerczyk A, Grzelak A, Janaszewska A, et al. Thiols as major determinants of the total antioxidant capacity. Biofactors 2003;17:75-82.
23. 2+-ATPase. Arch Biochem Biophys 1986;246:589-601.
24. +-ATPase activity induced by free radicals and by ischemia of kidney. Am J Physiol 1988;254:30-7.
25. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795-801.
26. Parks DA, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand 1986;548:87-99.
27. Della Corte E, Stirpe F. The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from the dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem J 1972;126:739-45.
28. Haenen GR, Vermeulen NP, Timmerman H, Bast A. Effect of thiols on lipid peroxidation in rat liver microsomes. Chem Biol Interact 1989;71:201-12.
29. Kako KJ. Free radical effects on membrane protein in myocardial ischemia/reperfusion injury. J Mol Cell Cardiol 1987;19:209-11.
30. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence. Lancet 1994;344:721-4.
31. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-81.
32. Yucel D, Aydogdu S, Senes M, Topkaya BC, Nebioglu S. Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy. Scand J Clin Lab Invest 2002;62:463-8.
33. Freeman LM, Brown DJ, Rush JE. Antioxidant status in dogs with idiopathic dilated cardiomyopathy. J Nutr 1998;128(12 Suppl):2768S-70S.
34. Baumer AT, Flesch M, Wang X, Shen Q, Feuerstein GZ, Bohm M. Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 2000;32:121-30.
35. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004;37:277-85.
36. Cicoira M, Zanolla L, Rossi A, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J 2002;143:1107-11.
37. Hoeper MM, Hohlfeld JM, Fabel H. Hyperuricaemia in patients with right or left heart failure. Eur Respir J 1999;13:682-5.